EC
MSGS icon

Elequin Capital’s Madison Square Garden MSGS Stock Holding History

Elequin Capital’s Portfolio MSGS Stock Details MSGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.3K Buy
+63
New +$22.3K ﹤0.01% 389

Other funds holding MSGS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Gates Foundation Trust
Gates Foundation Trust Kirkland, Washington $34.4B AUM 26.34% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Elequin Capital's MSGS Position: Q2 2026 in Review

Elequin Capital opened a new position in Madison Square Garden (MSGS) in Q2 2026: 63 shares worth $25.3K. The stake represents ﹤0.01% of the portfolio and ranks #389 among its holdings.

468 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • Elequin Capital held 63 shares of Madison Square Garden worth $25.3K as of Q2 2026.
  • Madison Square Garden was a new Elequin Capital position in Q2 2026.
  • Madison Square Garden made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #389 holding.
  • 468 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.